Nano in the brain: Is it safe?

A field that is developing alongside nanobiotechnology is something that you might call nanotoxicology. There is a fear that the same properties that make nanosize particles potentially helpful in fields like drug delivery might also make them harmful. For example, nanoparticles--because of their size--promise to finally break through the body's defensive blood-brain barrier and deliver therapeutics directly to the brain. However, researchers--and, increasingly, government regulators -- are concerned that not enough is known about possible unintended consequences of nanoparticles swirling around up there. A group of researchers, writing in the European Journal of Pharmaceutics and Biopharmaceutics, is proposing a method of setting up a cell model of the blood-brain barrier to use as a tool for screening nanoparticles' interactions. Establishing a model is a first step in determining that ever-present question in nanotech: "Is it safe?" Abstract

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.